Back
Tema Obesity & Cardiometabolic ETF Vs. Fidelity Disruptive Medicine ETF Industry Stock Comparison
Sell
3
HRTS
Tema Obesity & Cardiometabolic ETF
Last Price:
33.28
Seasonality Move:
--
Sell
46
FMED
Fidelity Disruptive Medicine ETF
Last Price:
25.74
Seasonality Move:
21.85%
Sell
3
Tema Obesity & Cardiometabolic ETF (HRTS)
is a Sell
Is Tema Obesity & Cardiometabolic ETF a Buy, Sell or Hold?
- The current Tema Obesity & Cardiometabolic ETF [HRTS] share price is $33.03. The Score for HRTS is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
- HRTS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Fidelity Disruptive Medicine ETF (FMED)
is a Sell
Is Fidelity Disruptive Medicine ETF a Buy, Sell or Hold?
- The current Fidelity Disruptive Medicine ETF [FMED] share price is $25.83. The Score for FMED is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRTS Stock Price Chart
What is Tema Obesity & Cardiometabolic ETF's stock price today?
-
The Tema Obesity & Cardiometabolic ETF share price today is $33.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTS is experiencing slight selling pressure.
FMED Stock Price Chart
What is Fidelity Disruptive Medicine ETF's stock price today?
-
The Fidelity Disruptive Medicine ETF share price today is $25.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMED is experiencing slight selling pressure.
HRTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 42.02 | Sell |
| Chaikin Money Flow: | -3633 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.03 - 33.95) | Sell |
| Bollinger Bands (100): | (33.09 - 34.75) | Sell |
FMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 48.39 | Sell |
| Chaikin Money Flow: | 62 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.7 - 26.14) | Sell |
| Bollinger Bands (100): | (24.41 - 26.11) | Buy |
HRTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.17 | Sell |
| 20-day SMA: | 33.54 | Sell |
| 50-day SMA: | 33.97 | Sell |
| 200-day SMA: | 33.23 | Sell |
| 8-day EMA: | 33.19 | Sell |
| 20-day EMA: | 33.45 | Sell |
| 50-day EMA: | 33.71 | Sell |
| 200-day EMA: | 32.8 | Buy |
FMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.77 | Buy |
| 20-day SMA: | 25.94 | Sell |
| 50-day SMA: | 25.98 | Sell |
| 200-day SMA: | 24.9 | Buy |
| 8-day EMA: | 25.8 | Buy |
| 20-day EMA: | 25.89 | Sell |
| 50-day EMA: | 25.79 | Buy |
| 200-day EMA: | 24.86 | Buy |
Tema Obesity & Cardiometabolic ETF Earnings Growth & HRTS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fidelity Disruptive Medicine ETF Earnings Growth & FMED Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tema Obesity & Cardiometabolic ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fidelity Disruptive Medicine ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||